Found 2031 results for "cancer"
Researchers propose using GLP-1 receptor agonists like semaglutide both before and after bariatric surgery, borrowing from cancer treatment models…
HPV-driven cancers may finally have a targeted therapeutic vulnerability, as breakthrough research demonstrates that directly blocking a key viral protein can…
The discovery of hybrid immune cells challenges fundamental assumptions about cellular identity in the human immune system. When specific genetic mutations…
Cancer immunotherapy resistance represents one of oncology's most pressing challenges, with many patients initially responding to PD-1 checkpoint inhibitors…
Understanding how latent viruses reactivate could unlock new strategies for managing chronic infections that affect billions worldwide. Epstein-Barr virus…
Cancer survivors face their greatest threat not from primary tumors, but from metastatic spread that can emerge months or years later. This reality has driven…
Laboratory-grown embryo models could transform how researchers study early human development and treat reproductive health challenges. These synthetic…
The gut microbiome's role in cancer progression has emerged as a critical frontier in oncology, with mounting evidence that bacterial communities can either…
The human thymus may hold untapped potential for extending healthy lifespan well beyond what medical science previously recognized. While this walnut-sized…
Understanding where genetic changes occur most frequently could revolutionize how we predict bacterial evolution, antibiotic resistance development, and even…
Precision medicine's promise hinges on targeting exactly the right molecular switches without triggering unwanted effects elsewhere in the body. The challenge…
PTPA gene loss occurs in 26% of malignant pleural mesothelioma patients and correlates with significantly decreased survival. When researchers restored PTPA…
Chemotherapy treatment in 128 acute myeloid leukemia patients significantly increased senescent cells expressing p16INK4a and p21Cip1 markers, with leukemic…
Radiation therapy induces cellular senescence in lymphatic endothelial cells, triggering increased expression of senescence markers p53, p21, and p16, along…
Three FDA-approved drugs targeting the same cellular machinery may work through surprisingly different molecular mechanisms, challenging assumptions about…
Cancer's ability to evade immune surveillance may have met a formidable new challenger. Tumors exploit metabolic pathways to suppress the very immune cells…
The potential for existing cardiovascular medications to combat cancer represents one of medicine's most promising cost-effective strategies, potentially…
The ability of cancer cells to develop resistance represents one of the most formidable challenges in oncology, potentially transforming successful treatments…
Understanding how to disable c-Myc could revolutionize cancer treatment, given this oncoprotein drives tumor growth in roughly seven out of ten cancers. The…
The precision of immune surveillance against cancer depends on molecular interactions far subtler than previously understood. When T cells patrol for threats…